Cargando…
Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer
We reported that Rev-erbα, a transcriptional repressor, is reduced in human gastric cancer and that it inhibits glycolysis in cultured gastric cancer cells. However, it is unclear whether Rev-erbα undergoes posttranslational modifications in gastric cancer. Here, we determined levels of Rev-erbα and...
Autores principales: | Ke, Chen, Xiaowen, Cheng, Yufeng, Wan, Dongchang, Li, Huaqing, Zhu, Zhengguang, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812611/ https://www.ncbi.nlm.nih.gov/pubmed/36618075 http://dx.doi.org/10.1155/2022/6291656 |
Ejemplares similares
-
Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression
por: Chen, Ke, et al.
Publicado: (2022) -
RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer
por: Wang, Xiaoshan, et al.
Publicado: (2021) -
REV-ERBα reduction is associated with clinicopathological features and prognosis in human gastric cancer
por: Wang, Xiaoshan, et al.
Publicado: (2018) -
Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012) -
Rev-erbα inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells
por: Tao, Linlin, et al.
Publicado: (2019)